What is the turnaround time for testing?

The system requires approximately 3.5 hours for a total run time with only 5 minutes of hands-on time.

What types of pathogens can this analyzer detect?

It detects 24/28 HPV genotypes and Mycobacterium tuberculosis complex including drug resistance genes.

What certifications does the product have?

The product is certified with CE and ISO13485.

Accurate Genotype Detection Platform: PCR and Hybridization Analyzer

Name: Accurate Genotype Detection Platform: PCR and Hybridization Analyzer
Brand: Beijing Bohui Innovation Biotechnology Group Co., Ltd
SKU: 2275645495

Beijing, ChinaBeijing Bohui Innovation Biotechnology Group Co., Ltd

US$18,000.00-23,000.00

1 Piece

Product profile

Customization

Available

Classification

Physiological Functions of Diagnosis and Monitoring Equipment

Type

Molecular Diagnostic Instrument

Model NO.

BHF-VI

Certification

CE, ISO13485

Group

Full Range

Detection Platform

PCR & Reverse DOT Blot Hybridization

Detection Modules

6 Modules

Sample Capacity

Electrical Specification

220V 50Hz 600va

Size

1000 X 610 X 690 mm

Voltage

220V

Power

600va

Weight

≤80kg

Specification

1000*610*690±10mm

Trademark

Bohui

Origin

China, Beijing

HS Code

9027509090

Key features

Automated Workflow: Auto-processes reagents, extracts DNA, amplifies PCR, and performs hybridization in one system.

Rapid Turnaround: Total run time of approximately 3.5 hours with only 5 minutes of hands-on time required.

High Sample Capacity: Supports 1-24 samples per run with 6 detection modules for efficient processing.

Comprehensive Detection: Detects 24/28 HPV genotypes and Mycobacterium tuberculosis complex with drug resistance genes.

CE & ISO13485 Certified: Meets international standards for safety and quality in molecular diagnostic instruments.

In-Stock Availability: All products are kept in stock and ship within 7 days for immediate deployment.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceExperienced TeamSelf-branded

Beijing Bohui Innovation Biotechnology Group Co., Ltd

Beijing, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 1 year CertifiedNearest Port: Tianjin PortAverage Response Time: ≤0.81h

AI-Powered supplier vetting

SummaryBohui Group is a Beijing-based high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. It reports CE and other product certifications, ISO9001:2015, ISO45001:2018, and ISO14001 management certifications. The supplier maintains documented procedures and records for corrective actions, complaint handling, supplier approval, and service assessment. It reports recent new-product activity and broad customization options, but does not provide 3D software design services. Service reach is limited: no overseas agents, branches, warehouses, or showrooms are reported, although the supplier has participated in WHX Labs Dubai 2026 and identifies Tianjin Port as its nearest port. Inventory capability and stated lead times within 15 workdays are reported. Manufacturing capacity is not supported by a valid contract with its affiliated subcontractor. Financial credibility cannot be determined from the provided financial information, and no customer cases are explicitly identified.

Supplier typeThe supplier is described as a combined company and a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. Its stated business scope covers technical development and sales of medical devices, medical analysis instruments, and related equipment.

CertificationsThe supplier reports CE and other product compliance certifications, plus ISO9001:2015, ISO45001:2018, ISO14001, and other management-system certifications. It also reports an environmental impact assessment report, providing explicit evidence of certification and environmental documentation.

After-Sales capabilityDocumented procedures and followed records exist for corrective and preventive actions, customer complaints, supplier approval, and service-capability assessment. However, the supplier reports no overseas agents or branches, overseas warehouse, or overseas showroom; it does report inventory capability, participation in WHX Labs Dubai 2026, and lead times within 15 workdays.

R&D capabilityThe company operates a 40,000 square-meter R&D center and reports R&D capability with new products introduced during the past year. Its business scope also includes technical development of medical devices and analytical instruments.

Production capacityThe supplier reports in-stock capability and order fulfillment within 15 workdays during both peak and off-season periods. However, it explicitly lacks a valid manufacturing-capacity contract with its factory and affiliated subcontractor, so production capacity is not fully secured by the provided evidence.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization. It does not provide 3D software design services, but the stated customization coverage is broad.